In line with these findings, NDRG1 KO resulted in enhanced glycolysis, implying that NDRG1 suppresses glycolysis and lactic acid production, which is coupled with reduced cell proliferation in ER + breast cancer cells. This evidence concerns the gene NDRG1 and breast cancer.